Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.
Van Dijk FS, Sillence DO.
Am J Med Genet A. 2014 Jun;164A(6):1470-81. doi: 10.1002/ajmg.a.36545. Epub 2014 Apr 8.
PMID:24715559
Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs.
Li S, Mei L, He C, Cai X, Wu H, Wu X, Liu Y, Feng Y, Song J.
Hum Cell. 2024 May;37(3):817-831. doi: 10.1007/s13577-024-01028-3. Epub 2024 Feb 20.
PMID:38379122
Algodystrophy in conjunction with van der Hoeve's syndrome.
Chérié-Lignière G, Tamborini U, Grosso P.
Clin Exp Rheumatol. 1995 May-Jun;13(3):361-5.
PMID:7554566
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study.
Glorieux FH, Langdahl B, Chapurlat R, De Beur SJ, Sutton VR, Poole KES, Dahir KM, Orwoll ES, Willie BM, Mikolajewicz N, Zimmermann E, Hosseinitabatabaei S, Ominsky MS, Saville C, Clancy J, MacKinnon A, Mistry A, Javaid MK.
J Bone Miner Res. 2024 Sep 2;39(9):1215-1228. doi: 10.1093/jbmr/zjae112.